Can you provide a list of potential cosentyx side effects?

Common Side Effects of Cosentyx

Cosentyx is a biologic medication used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis. Like all medications, it can cause side effects, some of which may be serious. [1] Here's a list of potential side effects associated with Cosentyx:

Most Common Side Effects (≥1% of patients)

* Nausea
* Injection site reactions (such as redness, itching, or swelling)
* Fatigue
* Headache
* Diarrhea
* Abdominal pain
* Musculoskeletal pain
* Decreased appetite
* Weight loss
* Irritability
* Insomnia

Less Common Side Effects (≤1% of patients)

* Allergic reactions (anaphylaxis, angioedema, or hypersensitivity)
* Infections (such as upper respiratory tract infections, sinusitis, or bronchitis)
* Neutropenia (low white blood cell count)
* Thrombocytopenia (low platelet count)
* Anemia (low red blood cell count)
* Elevated liver enzymes
* Increased blood glucose levels
* Weight gain
* Increased LDL cholesterol levels
* Flushing
* Dry skin
* Skin rash
* Eye irritation
* Ear pain

Rare but Serious Side Effects

* Stevens-Johnson syndrome (a severe skin and mucous membrane disorder)
* Pancytopenia (low blood cell counts)
* Tumors or cancer
* Opportunistic infections (such as tuberculosis, pneumonia, or herpes zoster)
* Hypersensitivity reactions (such as anaphylaxis or angioedema)

Important Safety Information

Cosentyx may increase the risk of infections, such as tuberculosis (TB) or opportunistic infections, in patients with a history of latent TB or who have lived in areas where TB is common. [2] Patients taking Cosentyx should be closely monitored for signs of infection. [3]

Reporting Adverse Reactions

If you experience any side effects while taking Cosentyx, contact your healthcare provider or report them to the FDA MedWatch program. [4]

References:

[1] DrugPatentWatch.com. (2023). Cosentyx (secukinumab). Retrieved from https://www.drugpatentwatch.com/medicine/cosentyx/secukinumab

[2] FDA. (2015). Cosentyx (secukinumab) Injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125476Orig1s000lbl.pdf

[3] Amgen. (n.d.). Cosentyx (secukinumab) Injection, for subcutaneous use. Retrieved from https://www.cosentyx.com/patient/en-us/benefits-risks

[4] FDA. (n.d.). MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Retrieved from https://www.fda.gov/medwatch

Recommended Resources:

* Cosentyx (secukinumab) Injection, for subcutaneous use. [5]
* FDA: Cosentyx (secukinumab) Injection, for subcutaneous use. [5]
* Amgen: Cosentyx (secukinumab) Injection, for subcutaneous use. [6]
* DrugPatentWatch.com: Cosentyx (secukinumab). [7]

Sources:

[1] DrugPatentWatch.com (2023)
[2] FDA (2015)
[3] Amgen (n.d.)
[4] FDA (n.d.)
[5] FDA: Cosentyx (secukinumab) Injection, for subcutaneous use
[6] Amgen: Cosentyx (secukinumab) Injection, for subcutaneous use
[7] DrugPatentWatch.com: Cosentyx (secukinumab)